{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:32:51Z","timestamp":1792672371259,"version":"4.5.0"},"reference-count":39,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Surg"],"published-print":{"date-parts":[[2022,10,1]]},"abstract":"<jats:sec id=\"ab-soi220063-4\"><jats:title>Importance<\/jats:title><jats:p>Adrenalectomy is the definitive treatment for multiple adrenal abnormalities. Advances in technology and genomics and an improved understanding of adrenal pathophysiology have altered operative techniques and indications.<\/jats:p><\/jats:sec><jats:sec id=\"ab-soi220063-5\"><jats:title>Objective<\/jats:title><jats:p>To develop evidence-based recommendations to enhance the appropriate, safe, and effective approaches to adrenalectomy.<\/jats:p><\/jats:sec><jats:sec id=\"ab-soi220063-6\"><jats:title>Evidence Review<\/jats:title><jats:p>A multidisciplinary panel identified and investigated 7 categories of relevant clinical concern to practicing surgeons. Questions were structured in the framework Population, Intervention\/Exposure, Comparison, and Outcome, and a guided review of medical literature from PubMed and\/or Embase from 1980 to 2021 was performed. Recommendations were developed using Grading of Recommendations, Assessment, Development and Evaluation methodology and were discussed until consensus, and patient advocacy representation was included.<\/jats:p><\/jats:sec><jats:sec id=\"ab-soi220063-7\"><jats:title>Findings<\/jats:title><jats:p>Patients with an adrenal incidentaloma 1 cm or larger should undergo biochemical testing and further imaging characterization. Adrenal protocol computed tomography (CT) should be used to stratify malignancy risk and concern for pheochromocytoma. Routine scheduled follow-up of a nonfunctional adrenal nodule with benign imaging characteristics and unenhanced CT with Hounsfield units less than 10 is not suggested. When unilateral disease is present, laparoscopic adrenalectomy is recommended for patients with primary aldosteronism or autonomous cortisol secretion. Patients with clinical and radiographic findings consistent with adrenocortical carcinoma should be treated at high-volume multidisciplinary centers to optimize outcomes, including, when possible, a complete R0 resection without tumor disruption, which may require en bloc radical resection. Selective or nonselective \u03b1 blockade can be used to safely prepare patients for surgical resection of paraganglioma\/pheochromocytoma. Empirical perioperative glucocorticoid replacement therapy is indicated for patients with overt Cushing syndrome, but for patients with mild autonomous cortisol secretion, postoperative day 1 morning cortisol or cosyntropin stimulation testing can be used to determine the need for glucocorticoid replacement therapy. When patient and tumor variables are appropriate, we recommend minimally invasive adrenalectomy over open adrenalectomy because of improved perioperative morbidity. Minimally invasive adrenalectomy can be achieved either via a retroperitoneal or transperitoneal approach depending on surgeon expertise, as well as tumor and patient characteristics.<\/jats:p><\/jats:sec><jats:sec id=\"ab-soi220063-8\"><jats:title>Conclusions and Relevance<\/jats:title><jats:p>Twenty-six clinically relevant and evidence-based recommendations are provided to assist surgeons with perioperative adrenal care.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamasurg.2022.3544","type":"journal-article","created":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T15:01:03Z","timestamp":1660748463000},"page":"870","source":"Crossref","is-referenced-by-count":263,"title":["American Association of Endocrine Surgeons Guidelines for Adrenalectomy"],"prefix":"10.1001","volume":"157","author":[{"given":"Linwah","family":"Yip","sequence":"first","affiliation":[{"name":"Division of Endocrine Surgery, University of Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan-Yang","family":"Duh","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Wachtel","sequence":"additional","affiliation":[{"name":"Department of Surgery, Hospital of the University of Pennsylvania, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilo","family":"Jimenez","sequence":"additional","affiliation":[{"name":"Division of Internal Medicine, Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cord","family":"Sturgeon","sequence":"additional","affiliation":[{"name":"Department of Surgery, Section of Endocrine Surgery, Northwestern University Feinberg School of Medicine, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cortney","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Kentucky College of Medicine, Lexington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Vel\u00e1zquez-Fern\u00e1ndez","sequence":"additional","affiliation":[{"name":"National Institute for Medical Sciences and Nutrition Salvador Zubir\u00e1n, Mexico City, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eren","family":"Berber","sequence":"additional","affiliation":[{"name":"Center for Endocrine Surgery, Cleveland Clinic, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary D.","family":"Hammer","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Michigan, Ann Arbor"},{"name":"Department of Cell & Developmental Biology, University of Michigan, Ann Arbor"},{"name":"Department of Molecular & Integrative Physiology, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Bancos","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Metabolism and Nutrition, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Surgery, Department of Internal Medicine, Columbia University College of Physicians and Surgeons, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Marko","sequence":"additional","affiliation":[{"name":"Department of Radiology and Imaging Sciences, National Institutes of Health Clinical Center, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilah F.","family":"Morris-Wiseman","sequence":"additional","affiliation":[{"name":"Division of Endocrine Surgery, Johns Hopkins Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marybeth S.","family":"Hughes","sequence":"additional","affiliation":[{"name":"Division of Surgical Oncology, Department of Surgery, Eastern Virginia Medical School, Norfolk"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masha J.","family":"Livhits","sequence":"additional","affiliation":[{"name":"Department of General Surgery, UCLA David Geffen School of Medicine, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi-Ah","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine, College of Medicine, Chosun University, Gwangju, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip W.","family":"Smith","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Virginia, Charlottesville"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Wilhelm","sequence":"additional","affiliation":[{"name":"Department of Surgery, University Hospitals Cleveland Medical Center, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia L.","family":"Asa","sequence":"additional","affiliation":[{"name":"Department of Pathology, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Thomas J.","family":"Fahey","sequence":"additional","affiliation":[{"name":"Division of Endocrine & Minimally Invasive Surgery, Department of Surgery, Weill Cornell Medical College, New York\u2013Presbyterian Hospital, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Travis J.","family":"McKenzie","sequence":"additional","affiliation":[{"name":"Division of Endocrine and Metabolic Surgery, Department of Surgery, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian E.","family":"Strong","sequence":"additional","affiliation":[{"name":"Department of Surgery, Gastric and Mixed Tumor Service, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy D.","family":"Perrier","sequence":"additional","affiliation":[{"name":"Section of Surgical Endocrinology, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"4","key":"soi220063r1","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence.","volume":"64","author":"Balshem","year":"2011","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"soi220063r2","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-16-0467","article-title":"Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors.","volume":"175","author":"Fassnacht","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"soi220063r3","doi-asserted-by":"publisher","first-page":"450","DOI":"10.4158\/EP.15.5.450","article-title":"American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons Medical Guidelines for the Management of Adrenal Incidentalomas: executive summary of recommendations.","volume":"15","author":"Zeiger","year":"2009","journal-title":"Endocr Pract"},{"issue":"2","key":"soi220063r4","doi-asserted-by":"publisher","first-page":"R51","DOI":"10.1530\/EJE-16-0461","article-title":"Management of Endocrine Disease: imaging for the diagnosis of malignancy in incidentally discovered adrenal masses: a systematic review and meta-analysis.","volume":"175","author":"Dinnes","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"soi220063r5","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1507\/endocrj.EJ18-0486","article-title":"A nationwide survey of adrenal incidentalomas in Japan: the first report of clinical and epidemiological features.","volume":"67","author":"Ichijo","year":"2020","journal-title":"Endocr J"},{"issue":"11","key":"soi220063r6","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/S2213-8587(20)30314-4","article-title":"Epidemiology of adrenal tumours in Olmsted County, Minnesota, USA: a population-based cohort study.","volume":"8","author":"Ebbehoj","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"soi220063r7","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1530\/EJE-17-0372","article-title":"Optimal follow-up strategies for adrenal incidentalomas: reappraisal of the 2016 ESE-ENSAT guidelines in real clinical practice.","volume":"177","author":"Hong","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"soi220063r8","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph16101872","article-title":"Malignancy risk and hormonal activity of adrenal incidentalomas in a large cohort of patients from a single tertiary reference center.","volume":"16","author":"Cyranska-Chyrek","year":"2019","journal-title":"Int J Environ Res Public Health"},{"issue":"9","key":"soi220063r9","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/S2213-8587(20)30218-7","article-title":"Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation study.","volume":"8","author":"Bancos","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"soi220063r10","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1530\/EJE-09-0234","article-title":"Recommended evaluation of adrenal incidentalomas is costly, has high false-positive rates and confers a risk of fatal cancer that is similar to the risk of the adrenal lesion becoming malignant: time for a rethink?","volume":"161","author":"Cawood","year":"2009","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"soi220063r11","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1210\/er.2002-0031","article-title":"The clinically inapparent adrenal mass: update in diagnosis and management.","volume":"25","author":"Mansmann","year":"2004","journal-title":"Endocr Rev"},{"issue":"2","key":"soi220063r12","doi-asserted-by":"publisher","first-page":"107","DOI":"10.7326\/M18-3630","article-title":"Natural history of adrenal incidentalomas with and without mild autonomous cortisol excess: a systematic review and meta-analysis.","volume":"171","author":"Elhassan","year":"2019","journal-title":"Ann Intern Med"},{"issue":"3","key":"soi220063r13","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1210\/jc.2013-3527","article-title":"Long-term follow-up in adrenal incidentalomas: an Italian multicenter study.","volume":"99","author":"Morelli","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"soi220063r14","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s12020-020-02476-1","article-title":"Clinical features, risk of mass enlargement, and development of endocrine hyperfunction in patients with adrenal incidentalomas: a long-term follow-up study.","volume":"71","author":"Falcetta","year":"2021","journal-title":"Endocrine"},{"issue":"5","key":"soi220063r15","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1055\/a-1079-4915","article-title":"Clinical characteristics and follow-up results of adrenal incidentaloma.","volume":"129","author":"Yilmaz","year":"2021","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"3","key":"soi220063r16","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1055\/s-0031-1295438","article-title":"Prevalence of primary aldosteronism in patient\u2019s cohorts and in population-based studies: a review of the current literature.","volume":"44","author":"Hannemann","year":"2012","journal-title":"Horm Metab Res"},{"issue":"4","key":"soi220063r17","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1002\/bjs.9742","article-title":"Systematic review of surgical treatment of subclinical Cushing\u2019s syndrome.","volume":"102","author":"Iacobone","year":"2015","journal-title":"Br J Surg"},{"issue":"5","key":"soi220063r18","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1210\/js.2019-00090","article-title":"Cardiovascular outcomes in autonomous cortisol secretion and nonfunctioning adrenal adenoma: a systematic review.","volume":"3","author":"Park","year":"2019","journal-title":"J Endocr Soc"},{"issue":"4","key":"soi220063r19","first-page":"1440","article-title":"Subclinical Cushing\u2019s syndrome in patients with adrenal incidentaloma: clinical and biochemical features.","volume":"85","author":"Rossi","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"soi220063r20","doi-asserted-by":"publisher","first-page":"R567","DOI":"10.1530\/ERC-19-0240","article-title":"Diagnosis and management of primary bilateral macronodular adrenal hyperplasia.","volume":"26","author":"Vassiliadi","year":"2019","journal-title":"Endocr Relat Cancer"},{"issue":"2","key":"soi220063r21","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2021.101486","article-title":"Role of unilateral adrenalectomy in bilateral adrenal hyperplasias with Cushing\u2019s syndrome.","volume":"35","author":"Meloche-Dumas","year":"2021","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"7","key":"soi220063r22","doi-asserted-by":"publisher","first-page":"2985","DOI":"10.1210\/jc.2018-02204","article-title":"Long-term outcome of primary bilateral macronodular adrenocortical hyperplasia after unilateral adrenalectomy.","volume":"104","author":"Osswald","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"soi220063r23","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1007\/s00268-013-2059-9","article-title":"The role of unilateral adrenalectomy in corticotropin-independent bilateral adrenocortical hyperplasias.","volume":"37","author":"Xu","year":"2013","journal-title":"World J Surg"},{"issue":"2","key":"soi220063r24","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1530\/EJE-14-0214","article-title":"Favorable long-term outcomes of bilateral adrenalectomy in Cushing\u2019s disease.","volume":"171","author":"O\u00dfwald","year":"2014","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"soi220063r25","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.amjsurg.2020.08.047","article-title":"Differences in outcomes of bilateral adrenalectomy in patients with ectopic ACTH producing tumor of known and unknown origin.","volume":"221","author":"Szabo Yamashita","year":"2021","journal-title":"Am J Surg"},{"issue":"5","key":"soi220063r26","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1097\/01.sla.0000251578.03883.2f","article-title":"Improved quality of life after bilateral laparoscopic adrenalectomy for Cushing\u2019s disease: a 10-year experience.","volume":"245","author":"Thompson","year":"2007","journal-title":"Ann Surg"},{"issue":"8","key":"soi220063r27","doi-asserted-by":"publisher","first-page":"2637","DOI":"10.1210\/jc.2014-1401","article-title":"Adrenal function after adrenalectomy for subclinical hypercortisolism and Cushing\u2019s syndrome: a systematic review of the literature.","volume":"99","author":"Di Dalmazi","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"soi220063r28","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1210\/jc.2013-2856","article-title":"Adjuvant therapies and patient and tumor characteristics associated with survival of adult patients with adrenocortical carcinoma.","volume":"99","author":"Else","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"soi220063r29","doi-asserted-by":"publisher","first-page":"3130","DOI":"10.1002\/cncr.v113:11","article-title":"Adrenocortical carcinoma in the United States: treatment utilization and prognostic factors.","volume":"113","author":"Bilimoria","year":"2008","journal-title":"Cancer"},{"issue":"5","key":"soi220063r30","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1007\/s00268-005-0329-x","article-title":"Extent of disease at presentation and outcome for adrenocortical carcinoma: have we made progress?","volume":"30","author":"Kebebew","year":"2006","journal-title":"World J Surg"},{"issue":"6","key":"soi220063r31","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and paraganglioma: an Endocrine Society clinical practice guideline.","volume":"99","author":"Lenders","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"soi220063r32","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1097\/MPA.0b013e31828e34a4","article-title":"Consensus guidelines for the management and treatment of neuroendocrine tumors.","volume":"42","author":"Kunz","year":"2013","journal-title":"Pancreas"},{"issue":"2","key":"soi220063r33","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nrc3648","article-title":"Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity.","volume":"14","author":"Dahia","year":"2014","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"soi220063r34","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ccell.2017.01.001","article-title":"Comprehensive molecular characterization of pheochromocytoma and paraganglioma.","volume":"31","author":"Fishbein","year":"2017","journal-title":"Cancer Cell"},{"issue":"2","key":"soi220063r35","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jamcollsurg.2012.10.012","article-title":"Long-term outcomes of surgical treatment for hereditary pheochromocytoma.","volume":"216","author":"Grubbs","year":"2013","journal-title":"J Am Coll Surg"},{"issue":"8","key":"soi220063r36","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.8898","article-title":"Comparison of pheochromocytoma-specific morbidity and mortality among adults with bilateral pheochromocytomas undergoing total adrenalectomy vs cortical-sparing adrenalectomy.","volume":"2","author":"Neumann","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"10","key":"soi220063r37","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1002\/bjs.4738","article-title":"Laparoscopic adrenalectomy.","volume":"91","author":"Assalia","year":"2004","journal-title":"Br J Surg"},{"issue":"6","key":"soi220063r38","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1089\/10926420152761941","article-title":"Laparoscopic adrenalectomy: the optimal surgical approach.","volume":"11","author":"Kebebew","year":"2001","journal-title":"J Laparoendosc Adv Surg Tech A"},{"issue":"1","key":"soi220063r39","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.surg.2017.04.028","article-title":"Each procedure matters: threshold for surgeon volume to minimize complications and decrease cost associated with adrenalectomy.","volume":"163","author":"Anderson","year":"2018","journal-title":"Surgery"}],"container-title":["JAMA Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamasurgery\/articlepdf\/2795363\/jamasurgery_yip_2022_oi_220063_1665179423.6644.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T15:20:33Z","timestamp":1665588033000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamasurgery\/fullarticle\/2795363"}},"subtitle":["Executive Summary"],"short-title":[],"issued":{"date-parts":[[2022,10,1]]},"references-count":39,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamasurg.2022.3544","relation":{},"ISSN":["2168-6254"],"issn-type":[{"value":"2168-6254","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10,1]]}}}